Cargando…
RELATIVE EFFECTIVENESS IN BREAST CANCER TREATMENT: A HEALTH PRODUCTION APPROACH
Background: Pharmaceuticals’ relative effectiveness has come to the fore in the policy arena, reflecting the need to understand how relative efficacy (what can work) translates into added benefit in routine clinical use (what does work). European payers and licensing authorities assess value for mon...
Autores principales: | Puig-Peiro, Ruth, Mason, Anne, Mestre-Ferrandiz, Jorge, Towse, Adrian, McGrath, Clare, Jonsson, Bengt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824961/ https://www.ncbi.nlm.nih.gov/pubmed/26788883 http://dx.doi.org/10.1017/S0266462315000720 |
Ejemplares similares
-
UNDERSTANDING VARIATIONS IN RELATIVE EFFECTIVENESS: A HEALTH PRODUCTION
APPROACH
por: Towse, Adrian, et al.
Publicado: (2015) -
Biosimilars: How Can Payers Get Long-Term Savings?
por: Mestre-Ferrandiz, Jorge, et al.
Publicado: (2016) -
PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND
RELATIVE EFFECTIVENESS RESEARCH
por: Moloney, Rachael, et al.
Publicado: (2015) -
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
por: Jönsson, Bengt, et al.
Publicado: (2018) -
A novel approach to identifying regulatory motifs in distantly related genomes
por: Van Hellemont, Ruth, et al.
Publicado: (2005)